Effects of tibial intraosseous and intravenous administration of Hextend on time of administration and hemodynamics in a hypovolemic swine model

Authors

  • James Wilson, BSN
  • Alex Passmore, BSN
  • Sephra Leger, BSN
  • Johnathon Lannan, BSN
  • Michael Bentley, PhD
  • Don Johnson, PhD

DOI:

https://doi.org/10.5055/ajdm.2016.0239

Keywords:

Hextend, intraosseous, hypovolemic shock

Abstract

Objective: To determine if there were significant differences between the tibial intraosseous (TIO) and intravenous (IV) administration of Hextend relative to time and in hemodynamics in a hypovolemic model.

Setting: Vivarium.

Subjects: Yorkshire swine; sample size was based on a power of 80 percent, α of 0.05, and a large effect size of 0.6. Swine were randomly assigned to one of three groups: TIO (n = 7), IV (n = 7), and control (n = 7).

Intervention: Swine were exsanguinated 30 percent of their blood volume. Hextend (500 mL) was administered either by the TIO or IV route; the control group received none.

Main Outcome: Time of administration of Hextend; systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), and stroke volume (SV) data were collected every 2 minutes and compared by group over 8 minutes.

Results: An independent t test determined that there was no significant difference between groups relative to time of administration (p = 0.001). A repeated analysis of variance found that there were no significant differences in SBP, DBP, MAP, HR, CO, and SV between the TIO and IV groups over 8 minutes (p > 0.05) but significant differences between both TIO and IV compared to the control group (p < 0.05).

Conclusion: TIO is an effective and easily used method to administer Hextend for patients in hypovolemic shock. Based upon the findings of this study, the TIO route might be considered the first choice for rapid vascular access and the administration of Hextend.

Author Biographies

James Wilson, BSN

Student, US Army Graduate Program in Anesthesia Nursing, Fort Sam Houston, San Antonio, Texas

Alex Passmore, BSN

Student, US Army Graduate Program in Anesthesia Nursing, Fort Sam Houston, San Antonio, Texas

Sephra Leger, BSN

Student, US Army Graduate Program in Anesthesia Nursing, Fort Sam Houston, San Antonio, Texas

Johnathon Lannan, BSN

Student, US Army Graduate Program in Anesthesia Nursing, Fort Sam Houston, San Antonio, Texas

Michael Bentley, PhD

Faculty Member, US Army Graduate Program in Anesthesia Nursing, Fort Sam Houston, San Antonio, Texas

Don Johnson, PhD

Faculty Member, US Army Graduate Program in Anesthesia Nursing, Fort Sam Houston, San Antonio, Texas

References

Fulkerson J, Lowe R, Anderson T, et al.: Effects of intraosseous tibial vs. intravenous vasopressin in a hypovolemic cardiac arrest model. West J Emerg Med. 2016; 17(2): 222-228.

Palmer L, Martin L: Traumatic coagulopathy—Part 1: Pathophysiology and diagnosis. J Vet Emerg Crit Care. 2014; 24(1): 63-74.

Rhee P, Joseph B, Pandit V, et al.: Increasing trauma deaths in the United States. Ann Surg. 2014; 260(1): 13-21.

Valparaiso AP, Vicente DA, Bograd BA, et al.: Modeling acute traumatic injury. J Surg Res. 2015; 194(1): 220-232.

Deakin CD, Nolan JP, Soar J, et al.: European Resuscitation Council guidelines for resuscitation 2010 section 4. Adult advanced life support. Resuscitation. 2010; 81(10): 1305-1352.

Link MS, Berkow LC, Kudenchuk PJ, et al.: Part 7: Adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015; 132(18)(suppl 2): S444-S464.

Nolan JP, Hazinski MF, Aickin R, et al.: Part 1: Executive summary: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation. 2015; 95: e1-31.

Soar J, Callaway CW, Aibiki M, et al.: Part 4: Advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation. 2015; 95: e71-120.

Laroche M: Intraosseous circulation from physiology to disease. Joint Bone Spine. 2002; 69(3): 262-269.

Lewis P, Wright C: Saving the critically injured trauma patient: A retrospective analysis of 1000 uses of intraosseous access. Emerg Med J. 2015; 32(6): 463-467.

Santos D, Carron PN, Yersin B, et al.: EZ-IO((R)) intraosseous device implementation in a pre-hospital emergency service: A prospective study and review of the literature. Resuscitation. 2013; 84(4): 440-445.

Burgert JM, Mozer J, Williams T, et al.: Effects of intraosseous transfusion of whole blood on hemolysis and transfusion time in a swine model of hemorrhagic shock: A pilot study. AANA J. 2014; 82(3): 198-202.

Johnson D, Dial J, Ard J, et al.: Effects of intraosseous and intravenous administration of hextend(R) on time of administration and hemodynamics in a Swine model. J Spec Oper Med. 2014; 14(1): 79-85.

Johnson D, Penaranda C, Phillips K, et al.: Effects of sternal intraosseous and intravenous administration of Hextend on time of administration and hemodynamics in a swine model of hemorrhagic shock. Am J Disaster Med. 2015; 10(1): 61-67.

Grocott MP, Mythen MG, Gan TJ: Perioperative fluid management and clinical outcomes in adults. Anesth Analg. 2005; 100(4): 1093-1106.

Carness JM, Russell JL, MeL R, et al.: Fluid resuscitation using the intraosseous route: Infusion with lactated Ringer's and hetastarch. Military Med. 2012; 177(2): 222-228.

Nielsen VG: Resuscitation with Hextend decreases endogenous circulating heparin activity and accelerates clot initiation after hemorrhage in the rabbit. Anesth Analg. 2001; 93(5): 1106-1110.

Todd SR, Malinoski D, Muller PJ, et al.: Hextend attenuates hypercoagulability after severe liver injury in swine. J Trauma. 2005; 59(3): 589-593; discussion 593-584.

Butler FK, Holcomb JB, Schreiber MA, et al.: Fluid resuscitation for hemorrhagic shock in tactical combat casualty care: TCCC guidelines change 14-01 - 2 June 2014. J Spec Oper Med. 2014; 14(3): 13-38.

Fiser DH: Intraosseous infusion. N Engl J Med. 1990; 322(22): 1579-1581.

Blebea JS, Houseni M, Torigian DA, et al.: Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. Seminars Nuclear Med. 2007; 37(3): 185-194.

Paquette S, Gordon C, Bradtmiller B: Anthropometric Survey II Pilot Study: Methods and Summary Statistics. Natick, MA: US Army Natick Soldier Research, Development and Engineering Center; 2009: 74-75.

Swindle MM: The development of swine models in drug discovery and development. Future Med Chem. 2012; 4(14): 1771-1772.

Swindle MM, Makin A, Herron AJ, et al.: Swine as models in biomedical research and toxicology testing. Vet Pathol. 2012; 49(2): 344-356.

Hannon JP, Bossone CA, Wade CE: Normal physiological values for conscious pigs used in biomedical research. Lab Animal Sci. 1990; 40(3): 293-298.

Costantino TG, Parikh AK, Satz WA, et al.: Ultrasonography-guided peripheral intravenous access versus traditional approaches in patients with difficult intravenous access. Ann Emerg Med. 2005; 46(5): 456-461.

Lapostolle F, Catineau J, Garrigue B, et al.: Prospective evaluation of peripheral venous access difficulty in emergency care. Intensive Care Med. 2007; 33(8): 1452-1457.

Paxton JH, Knuth TE, Klausner HA: Proximal humerus intraosseous infusion: A preferred emergency venous access. J Trauma. 2009; 67(3): 606-611.

Published

07/01/2016

How to Cite

Wilson, BSN, J., A. Passmore, BSN, S. Leger, BSN, J. Lannan, BSN, M. Bentley, PhD, and D. Johnson, PhD. “Effects of Tibial Intraosseous and Intravenous Administration of Hextend on Time of Administration and Hemodynamics in a Hypovolemic Swine Model”. American Journal of Disaster Medicine, vol. 11, no. 3, July 2016, pp. 193-01, doi:10.5055/ajdm.2016.0239.

Most read articles by the same author(s)

1 2 > >>